What's in Draig Therapeutics Ltd's pipeline?

Draig Therapeutics Ltd has 1 drugs in our index: 0 marketed, 0 filed, 0 in Phase 3, 1 in Phase 2, 0 in Phase 1.

Which companies overlap with Draig Therapeutics Ltd's portfolio?

Top competitors by shared drug class: AstraZeneca, Centre Leon Berard, Fujian Cancer Hospital, GBG Forschungs GmbH, GERCOR - Multidisciplinary Oncology Cooperative Group.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/draig-therapeutics-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Draig Therapeutics Ltd — Portfolio Competitive Intelligence Brief

Draig Therapeutics Ltd pipeline: 0 marketed, 0 filed, 0 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 0 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

No leading-phase drugs tracked for this sponsor.

Therapeutic area mix

Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

AstraZeneca · 1 shared drug class
Centre Leon Berard · 1 shared drug class
Fujian Cancer Hospital · 1 shared drug class
GBG Forschungs GmbH · 1 shared drug class
GERCOR - Multidisciplinary Oncology Cooperative Group · 1 shared drug class
Hoffmann-La Roche · 1 shared drug class
Institut Bergonié · 1 shared drug class
Jiangsu Simcere Pharmaceutical Co., Ltd. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Draig Therapeutics Ltd:

Cite this brief

Drug Landscape (2026). Draig Therapeutics Ltd — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/draig-therapeutics-ltd. Accessed 2026-05-16.